Professional Documents
Culture Documents
1 neonate 1
infant 1 11 children
12-18 adolescent 1
3 ibuprofen syrup,
brompheniramine/phenylephrine syrup carbocysteine syrup
25
25
ampicillin cloxacillin
gastric emptying time intestinal
transit
onset of action
3,4
o
26
1 : bilirubin
free bilirubin
o metabolism
hepatic enzymatic
metabolism8 chloramphenicol glucuronyl
transferase gray baby syndrome
first-pass metabolism
enzyme
(halflife)
diazepam
24-48 (infant)
10-12 6
o infant
enzyme
6,8
o glomerular filtration rate (GFR)
0.6-0.8
3 6
?
ibuprofen syrup ,
brompheniramine/phenylephrine syrup
9
carbocysteine syrup
10
/
11,12
27
27
o (contraindication/ precaution) ibuprofen
NSAIDs
thromboxane A2
Dengue fever
ibuprofen
13
paracetamol
paracetamol
ibuprofen
(excipient)
alcohol sucrose
1 aspartame
phenylketonuria phenylalanine lactose
lactose intolerance
1
28
o (drug dosing)
14
2
3-4
ibuprofen oral sus
pension drug information handbook
4-10 mg/kg/dose every 6-8 hours
cloxacillin 25-50 mg/
kg/day in divided doses every 6 hours
4 6
cloxacillin
4
2 (double check)
40
1
paracetamol syrup
3
29
29
o (drug
duplication)
dextromethorphan paracetamol
- paracetamol
o (medication
adherence)
amoxicillin
3 8 2 12
1,15
30
14
o
14
o
o
2 (, , )
o
7
azithromycin microspheres suspension
control-release formulation
31
31
o 9
o
32
1. Buck ML. Pediatric pharmacotherapy. In: Alldredge BK, Corelli RL, Ernst ME, et al., eds. Applied therapeutics.
10th ed. China: Lippincott Williams & Wilkins; 2013:2265-76.
2. Udkow G. Pediatric clinical pharmacolgy. Am J Dis Child 1978;132:1025-32.
3. Silverio J, Poole JW. Serum concentrations of ampicillin in newborn infants after oral administration. Pediatrics
1973;51:578-80.
4. McCracken GH, Jr. Pharmacological basis for antimicrobial therapy in newborn infants. Am J Dis Child
1974;128:407-19.
5. Chosidow O. Clinical practices. Scabies. N Engl J Med 2006;354:1718-27.
6. Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related
differences and therapeutic implications. Clinical pharmacokinetics 1980;5:485-527.
7. Odell GB. The dissociation of bilirubin from albumin and its clinical implications. J Pediatr 1959;55:268-79.
8. Triggs EJ, Hooper WD, Dickinson RG. The influence of age on drug metabolism. Implications for drug dosage.
The Medical journal of Australia 1984;141:823-7.
9. Ryan T, Brewer M, Small L. Over-the-counter cough and cold medication use in young children. Pediatric
nursing 2008;34:174-80, 84.
10. Chalumeau M, Duijvestijn YC. Acetylcysteine and carbocysteine for acute upper and lower respiratory
tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst
Rev 2013;5:CD003124.
11. Chiappini E, Parretti A, Becherucci P, et al. Parental and medical knowledge and management of fever in
Italian pre-school children. BMC pediatrics 2012;12:97.
12. Walsh A, Edwards H. Management of childhood fever by parents: literature review. Journal of advanced
nursing 2006;54:217-27.
13. Sibbald B. Ibuprofen should go behind-the-counter says expert panel. Canadian Medical Association
Journal 2006;175:233.
14. Baber N, Pritchard D. Dose estimation for children. British journal of clinical pharmacology 2003;56:489-93.
15. Dundee FD, Dundee DM, Noday DM. Pediatric counseling and medication management services: opportunities
for community pharmacists. Journal of the American Pharmaceutical Association (Washington,DC : 1996)
2002;42:556-66; quiz 66-7.
33
33